These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15358177)

  • 1. Determination of sensitive positions to mutations in human p53 protein.
    Wu G; Yan S
    Biochem Biophys Res Commun; 2004 Aug; 321(2):313-9. PubMed ID: 15358177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of amino acid pairs in human p53 protein sensitive to mutations/variants by means of a random approach.
    Wu G; Yan S
    J Mol Model; 2003 Oct; 9(5):337-41. PubMed ID: 14517612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers.
    Lamolle G; Marin M; Alvarez-Valin F
    Mutat Res; 2006 Aug; 600(1-2):102-12. PubMed ID: 16650445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective pressures at a codon-level predict deleterious mutations in human disease genes.
    Arbiza L; Duchi S; Montaner D; Burguet J; Pantoja-Uceda D; Pineda-Lucena A; Dopazo J; Dopazo H
    J Mol Biol; 2006 May; 358(5):1390-404. PubMed ID: 16584746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of amino acid pairs sensitive to variants in human low-density lipoprotein receptor precursor by means of a random approach.
    Wu G; Yan S
    J Biochem Mol Biol Biophys; 2002 Dec; 6(6):401-6. PubMed ID: 14972795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of novel tumour-derived p53 mutations on the transformation of NIH-3T3 cells.
    Donninger H; Binder A; Bohm L; Parker MI
    Biol Chem; 2008 Jan; 389(1):57-67. PubMed ID: 18095870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The salivary tip of the p53 mutagenesis iceberg: novel insights.
    Ben-Izhak O; Laster Z; Akrish S; Muska E; Gan S; Nagler RM
    Cancer Biomark; 2009; 5(1):23-31. PubMed ID: 19242059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
    Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
    Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of void volumes in proteins and application to stability of the p53 tumour suppressor protein.
    Cuff AL; Martin AC
    J Mol Biol; 2004 Dec; 344(5):1199-209. PubMed ID: 15561139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations.
    Kamihira S; Terada C; Sasaki D; Yanagihara K; Tsukasaki K; Hasegawa H; Yamada Y
    Eur J Haematol; 2009 Apr; 82(4):301-7. PubMed ID: 19220422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prediction of the possible tertiary structure alterations of p53 protein following point mutation in p53 gene condon 282 in lung cancer cells].
    Du CH; Xu J; Zhong NS
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1458-9. PubMed ID: 17062352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation features of 215 polymerase proteins from different influenza A viruses.
    Wu G; Yan S
    Med Sci Monit; 2005 Oct; 11(10):BR367-72. PubMed ID: 16192894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma.
    Salinas-Sánchez AS; Atienzar-Tobarra M; Lorenzo-Romero JG; Sánchez-Sánchez F; Giménez-Bachs JM; Donate-Moreno MJ; Pastor-Navarro H; Hernández-Millán I; Segura-Martín M; Escribano-Martínez J
    Urol Int; 2007; 79(4):321-7. PubMed ID: 18025850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of p53 exon 4 mutations in soft tissue sarcoma.
    Das P; Kotilingam D; Korchin B; Liu J; Yu D; Lazar AJ; Pollock RE; Lev D
    Cancer; 2007 Jun; 109(11):2323-33. PubMed ID: 17429838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of distributions of amino acids in the primary structure of tumor suppressor p53 family according to the random mechanism.
    Wu G; Yan SM
    J Mol Model; 2002 May; 8(5):191-8. PubMed ID: 12111387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UMD TP53 database and website: update and revisions.
    Hamroun D; Kato S; Ishioka C; Claustres M; Béroud C; Soussi T
    Hum Mutat; 2006 Jan; 27(1):14-20. PubMed ID: 16278824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic computational alanine scanning: application to p53 oligomerization.
    Chong LT; Swope WC; Pitera JW; Pande VS
    J Mol Biol; 2006 Mar; 357(3):1039-49. PubMed ID: 16457841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 Gene mutations in sporadic colorectal carcinoma in Guangxi region.
    Gao F; Li C; Li W; Chen L; Tang Z; Tang W
    Cancer Invest; 2006 Nov; 24(7):689-95. PubMed ID: 17118779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast.
    Grochova D; Vankova J; Damborsky J; Ravcukova B; Smarda J; Vojtesek B; Smardova J
    Oncogene; 2008 Feb; 27(9):1243-52. PubMed ID: 17724467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.